Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 3
2011 3
2012 3
2013 8
2014 12
2015 11
2016 16
2017 11
2018 16
2019 21
2020 17
2021 23
2022 31
2023 19
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

170 results

Results by year

Filters applied: . Clear all
Page 1
Therapeutic options in thymomas and thymic carcinomas.
Muto Y, Okuma Y. Muto Y, et al. Among authors: okuma y. Expert Rev Anticancer Ther. 2022 Apr;22(4):401-413. doi: 10.1080/14737140.2022.2052278. Epub 2022 Apr 4. Expert Rev Anticancer Ther. 2022. PMID: 35266421 Review.
Unarranged territory in uncommon EGFR mutations.
Fujii H, Okuma Y. Fujii H, et al. Among authors: okuma y. Transl Lung Cancer Res. 2022 Jul;11(7):1233-1236. doi: 10.21037/tlcr-22-478. Transl Lung Cancer Res. 2022. PMID: 35958324 Free PMC article. No abstract available.
C-CAT: The National Datacenter for Cancer Genomic Medicine in Japan.
Kohno T, Kato M, Kohsaka S, Sudo T, Tamai I, Shiraishi Y, Okuma Y, Ogasawara D, Suzuki T, Yoshida T, Mano H. Kohno T, et al. Among authors: okuma y. Cancer Discov. 2022 Nov 2;12(11):2509-2515. doi: 10.1158/2159-8290.CD-22-0417. Cancer Discov. 2022. PMID: 36321305 Free PMC article.
Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy.
Shirasawa M, Yoshida T, Shiraishi K, Takigami A, Takayanagi D, Imabayashi T, Matsumoto Y, Masuda K, Shinno Y, Okuma Y, Goto Y, Horinouchi H, Yotsukura M, Yoshida Y, Nakagawa K, Tsuchida T, Hamamoto R, Yamamoto N, Motoi N, Kohno T, Watanabe SI, Ohe Y. Shirasawa M, et al. Among authors: okuma y. Lung Cancer. 2023 May;179:107183. doi: 10.1016/j.lungcan.2023.107183. Epub 2023 Mar 25. Lung Cancer. 2023. PMID: 37037178
Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Deficient Thoracic Tumor.
Shinno Y, Yoshida A, Masuda K, Matsumoto Y, Okuma Y, Yoshida T, Goto Y, Horinouchi H, Yamamoto N, Yatabe Y, Ohe Y. Shinno Y, et al. Among authors: okuma y. Clin Lung Cancer. 2022 Jul;23(5):386-392. doi: 10.1016/j.cllc.2022.03.005. Epub 2022 Apr 29. Clin Lung Cancer. 2022. PMID: 35618627
170 results